Menu Search
Equities

Ceylon Hospitals PLC

CHL.N0000:CSE

Ceylon Hospitals PLC

Actions
Health CareHealth Care Providers
  • Price (LKR)118.00
  • Today's Change0.00 / 0.00%
  • Shares traded526.00
  • 1 Year change-9.49%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ceylon Hospitals PLC is a Sri Lanka-based company that is engaged in providing healthcare services and laboratory services. The Company operates under the brand name Durdans. Its subsidiaries include Durdans Heart Centre (Pvt) Ltd, Durdans Medical and Surgical Hospital (Pvt) Ltd, Amrak Institute of Medical Sciences (Pvt) Ltd and Ceygen Biotech (Pvt) Ltd. The Durdans Heart Centre (Pvt) Ltd is engaged in providing preventive cardiac care services and cardiac surgical care. The Durdans Medical and Surgical Hospital (Pvt) Ltd is engaged in providing healthcare services. The Amrak Institute of Medical Sciences (Pvt) Ltd is involved in providing allied medical science courses. The Ceygen Biotech (Pvt) Ltd is involved in supplying molecular biological, biochemical, biotechnological, test kits, equipment and accessories for molecular diagnostics and research.

  • Revenue in LKR (TTM)8.94bn
  • Net income in LKR269.56m
  • Incorporated1945
  • Employees2.03k
  • Location
    Ceylon Hospitals PLC#3 Alfred Place, Colombo 03COLOMBO 03Sri LankaLKA
  • Phone+94 112140000
  • Fax+94 112575302
  • Websitehttps://www.durdans.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.